Summary
A research-focused overview of peptides studied for longevity and healthy ageing — covering telomere biology, mitochondrial function, epigenetic regulation, and anti-senescence compounds.
The Biology of Ageing: What Peptides Can Target
Ageing is not a single process — it is the accumulated failure of multiple overlapping biological systems. The Hallmarks of Ageing framework (Lopez-Otin et al., 2013, updated 2023) describes nine primary drivers:
- Genomic instability
- Telomere attrition ← Epitalon research target
- Epigenetic alterations
- Loss of proteostasis
- Deregulated nutrient sensing
- Mitochondrial dysfunction ← SS-31, MOTS-c research targets
- Cellular senescence
- Stem cell exhaustion
- Altered intercellular communication
NAD+ depletion is considered a unifying mechanism that contributes to multiple hallmarks simultaneously — senescence, mitochondrial dysfunction, and genomic instability.
Peptide-based longevity research concentrates on the hallmarks most directly accessible through peptide mechanisms: telomere biology, mitochondrial function, and metabolic homeostasis.
Epitalon: Telomere Biology and Pineal Signalling
Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly) developed by the St. Petersburg Institute of Bioregulation and Gerontology from research beginning in the 1980s. It is derived from epithalamin — a peptide fraction extracted from the bovine pineal gland — and represents the synthetic, sequence-defined version of the naturally occurring molecule.
Telomerase activation research:
The most cited property of epitalon in longevity research is its apparent ability to activate telomerase — the enzyme responsible for maintaining and elongating telomere sequences at chromosome ends.
Key findings from published research:
- Khavinson et al. (2003): Epitalon induced telomerase activity and telomere elongation in human somatic cells (fetal fibroblasts), which do not normally express telomerase in adult life.
- Rodent studies show extended mean and maximum lifespan in treated animals compared to controls.
- Drosophila models confirm statistically significant lifespan extension.
Pineal and neuroendocrine effects:
The pineal gland is the primary source of melatonin, which modulates circadian rhythm, immune function, and antioxidant defence. The gland degrades with age — calcification reduces pineal output substantially by middle age. Epitalon's origin from pineal tissue and its effects on melatonin synthesis in research models position it as a neuroendocrine modulator as well as a telomere biology compound.
Long-term human observational data:
Russian longitudinal studies following elderly patients (mean age 75+) who received periodic epitalon cycles over 15 years reported:
- Reduced all-cause mortality versus control groups
- Reduced cancer incidence
- Improved cardiovascular and immunological markers
These findings are from a single research tradition and have not been replicated in independent, large-scale Western clinical trials. They are promising but require independent confirmation.
SS-31 (Elamipretide): Mitochondrial Membrane Targeting
Mitochondrial dysfunction is considered both a cause and a consequence of ageing — a vicious cycle in which damaged mitochondria produce more reactive oxygen species (ROS), which damage mitochondria further.
The central structural failure point is cardiolipin — a unique phospholipid found only in the inner mitochondrial membrane, essential for:
- Organising the electron transport chain complexes (I–IV) into supercomplexes
- Maintaining the proton gradient that drives ATP synthase
- Regulating mitochondrial fission, fusion, and apoptotic signalling
Cardiolipin is highly susceptible to oxidative damage due to its polyunsaturated fatty acid side chains. With ageing, cardiolipin becomes progressively oxidised, destabilising the electron transport chain and reducing ATP production efficiency.
SS-31's mechanism:
SS-31 is a synthetic tetrapeptide with a unique alternating aromatic-cationic structure that allows it to selectively accumulate in the inner mitochondrial membrane due to electrostatic affinity. There, it:
- Binds cardiolipin and prevents its oxidation
- Stabilises electron transport chain supercomplex organisation
- Reduces mitochondrial ROS production
- Restores age-related declines in ATP synthesis efficiency
Human evidence:
Unlike most longevity compounds, SS-31 has published Phase 2 human clinical trial data — primarily from heart failure and diabetic kidney disease research. The EMBRACE-HF trial showed improvements in exercise capacity in heart failure patients. While these are disease state populations, the mitochondrial mechanisms are directly relevant to age-related energy decline.
MOTS-c: The Mitochondrial-Encoded Hormone
MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA-c) is a small peptide encoded in the mitochondrial genome — not the nuclear genome — making it one of a recently discovered class of mitochondrial-derived peptides (MDPs) that act as metabolic hormones.
What MOTS-c does:
- Activates AMPK (AMP-activated protein kinase) — the master cellular energy sensor and longevity-relevant metabolic regulator
- Improves skeletal muscle insulin sensitivity
- Reduces adipogenesis and diet-induced obesity in mouse models
- Modulates one-carbon metabolism and folate cycle activity
- Migrates to the nucleus under stress conditions and activates the integrated stress response
MOTS-c and natural ageing:
Plasma MOTS-c levels decline significantly with age in humans. A study of centenarians and their offspring found higher circulating MOTS-c levels compared to age-matched controls — suggesting MOTS-c is a naturally occurring mediator of longevity rather than simply a therapeutic compound.
Exercise increases circulating MOTS-c, which may partly explain exercise's longevity benefits at the molecular level.
NAD+: The Molecular Currency of Cellular Health
NAD+ is a coenzyme present in every living cell, serving as an essential cofactor for:
- Cellular respiration and ATP production (via the electron transport chain)
- Sirtuins (SIRT1–7) — NAD+-dependent deacetylases that regulate DNA repair, inflammation, metabolism, and gene expression
- PARP enzymes — which repair DNA strand breaks (depleted by cumulative DNA damage with ageing)
- CD38 — an enzyme that consumes NAD+ and is upregulated with ageing, inflammation, and senescence
The NAD+ decline:
Tissue NAD+ levels fall approximately 50% between early adulthood and late middle age. This decline is driven by reduced biosynthesis, increased consumption by CD38 and PARPs under oxidative stress, and mitochondrial dysfunction that reduces recycling efficiency.
NAD+ precursors and direct supplementation:
NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are oral precursors that raise NAD+ levels systemically. Human trials with NMN have shown improved muscle function, insulin sensitivity, and mitochondrial activity in older adults.
Direct NAD+ IV administration bypasses the biosynthetic pathways entirely, delivering the molecule directly to cells — relevant for researchers studying rapid or high-dose NAD+ replenishment protocols.
The Longevity Peptide Landscape
| Compound | Primary mechanism | Evidence strength | Human data |
|---|---|---|---|
| Epitalon | Telomerase activation, pineal modulation | Moderate preclinical + Russian long-term observational | Long-term observational (Russian) |
| SS-31 | Cardiolipin stabilisation, mitochondrial ETC | Strong preclinical + Phase 2 clinical (disease states) | Phase 2 clinical |
| MOTS-c | AMPK activation, mitochondrial stress response | Strong preclinical | No published clinical trials |
| NAD+/NMN | Sirtuin activation, DNA repair, mitochondrial function | Moderate-strong preclinical + early clinical | Multiple human trials |
Stacking Considerations in Longevity Research
Several longevity researchers have proposed multi-mechanism protocols based on the complementarity of these compounds:
Epitalon + SS-31: Addresses both telomere biology (upstream, nuclear) and mitochondrial function (cytoplasmic). Different mechanisms, potentially additive.
MOTS-c + NAD+: Both converge on AMPK and mitochondrial metabolic efficiency from different entry points. MOTS-c acts through the mitochondrial stress response; NAD+ through sirtuin and PARP pathways.
These combinations are studied individually in preclinical models; direct combination evidence in humans is absent.
Frequently Asked Questions
Is epitalon the only peptide that activates telomerase?
No — other compounds including TA-65 (a cycloastragenol-based telomerase activator), and some herbal extracts, have been studied for telomerase activity. Epitalon is distinctive for being a short peptide with a defined sequence and published human observational data spanning decades.
Can SS-31 improve energy levels in healthy ageing?
SS-31's phase 2 data comes from heart failure patients, where mitochondrial dysfunction is severe. Whether comparable benefits translate to age-related energy decline in otherwise healthy individuals is unstudied in controlled trials. The mechanism is directly relevant — mitochondrial energy production declines with age in healthy populations — but clinical evidence is lacking.
How does MOTS-c compare to exercise for longevity?
MOTS-c activates many of the same cellular pathways stimulated by exercise — AMPK, mitochondrial biogenesis, insulin sensitivity improvement. It is studied as a potential "exercise mimetic" in sedentary and elderly populations for whom exercise is limited. It is not proposed as an exercise replacement but as a pharmacological activator of pathways exercise cannot reach.
What is the relationship between NAD+ and senolytics?
Senolytics (compounds that clear senescent cells) and NAD+ replenishment are complementary strategies. Senescent cells accumulate with age, suppress NAD+ through CD38 upregulation, and drive inflammation. Clearing them (via senolytics like quercetin/dasatinib) reduces CD38 activity; restoring NAD+ reactivates the sirtuins and DNA repair mechanisms that senescent accumulation had compromised. The two approaches are often studied in combination.
Source Research-Grade Longevity Compounds in Bali
BioPepTech lists epitalon, NAD+, SS-31, and MOTS-c for research use in Bali. Review product pages for current formats, available batch records, and delivery confirmation.
- Epitalon — Synthetic telomere biology tetrapeptide
- NAD+ Pen (IGNITE) — Pre-filled NAD+ pen for rapid bioavailability research
- SS-31 — Cardiolipin-targeting mitochondrial peptide
- MOTS-c — Mitochondrial-derived metabolic hormone
A free expert consultation is included with every order — our research team can help match compounds to your specific longevity protocol objectives.
References
Khavinson VKh et al. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-2.
Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-50.
Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-54.
Yoshino J et al. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018;27(3):513-28.
Anisimov VN et al. Effect of Epitalon on the lifespan increase in Drosophila melanogaster. Mech Ageing Dev. 2004;125(2):123-9.
Research Use Only Disclaimer
BioPepTech products are supplied strictly for research use only. They are not intended for human consumption and are not intended to diagnose, treat, cure, or prevent disease.
Safety & Regulatory Note
Longevity compounds are not approved for anti-ageing indications. Epitalon's primary evidence base comes from Russian research that has not been independently replicated at scale. SS-31 human data is primarily from disease states (heart failure, kidney disease), not healthy ageing populations. NAD+ IV administration carries infusion-related risks. All compounds are for research use only.
References
- 1.Khavinson VKh et al. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003.
- 2.Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014.
- 3.Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015.
- 4.Yoshino J et al. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018.
- 5.Anisimov VN et al. Effect of Epitalon on the lifespan increase in Drosophila melanogaster. Mech Ageing Dev. 2004.